CHARACTERIZATION OF P388 LEUKEMIA RESISTANT TO MITOMYCIN-C (MMC)

被引：0
|
作者：
ROSE, WC [1 ]
HUFTALEN, JB [1 ]
BRADNER, WT [1 ]
SCHURIG, JE [1 ]
机构：
[1] BRISTOL MYERS CO INC,SYRACUSE,NY 13221
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1986年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：260 / 260
页数：1
相关论文
共 50 条
  • [1] COMPARISON OF UPTAKE OF MITOMYCIN-C AND KW-2149 BY MURINE P388 LEUKEMIA-CELLS SENSITIVE OR RESISTANT TO MITOMYCIN-C
    KOBAYASHI, E
    OKABE, M
    KONO, M
    ARAI, H
    KASAI, M
    GOMI, K
    LEE, JH
    INABA, M
    TSURUO, T
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1993, 32 (01) : 20 - 24
  • [2] DNA ALKYLATION BY MITOMYCIN-C IN P388 MURINE LEUKEMIA-CELLS
    IRACKI, T
    PAN, S
    BACHUR, NR
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 213 - 213
  • [3] ANTI-TUMOR ACTIVITY OF 7-N-PHENYL DERIVATIVES OF MITOMYCIN-C IN THE LEUKEMIA P388 SYSTEM
    IMAI, R
    ASHIZAWA, T
    URAKAWA, C
    MORIMOTO, M
    NAKAMURA, N
    [J]. GANN, 1980, 71 (04): : 560 - 562
  • [4] ISOLATION AND CHARACTERIZATION OF A MURINE P388 LEUKEMIA LINE RESISTANT TO THIARABINE
    Waud, William R.
    Parker, William B.
    Gilbert, Karen S.
    Secrist, John A., III
    [J]. NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2012, 31 (1-3): : 14 - 27
  • [5] CHARACTERIZATION OF THE MECHANISM OF RESISTANCE OF A SUBLINE OF P388 LEUKEMIA RESISTANT TO AMSACRINE
    HOFMANN, GA
    BARTUS, JO
    MONG, SM
    SUNG, CM
    MATTERN, MR
    JOHNSON, RK
    MIRABELLI, CK
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 269 - 269
  • [6] ISOLATION AND CHARACTERIZATION OF A MURINE P388 LEUKEMIA LINE RESISTANT TO CLOFARABINE
    Waud, William R.
    Gilbert, Karen S.
    Parker, William B.
    Secrist, John A., III
    [J]. NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2011, 30 (11): : 826 - 838
  • [7] ANTICANCER ACTIVITY OF MOUSE INTERFERON (IFN) ALONE AND IN COMBINATION WITH CIS-DICHLORODIAMMINEPLATINUM II (CIS-DDPT) OR MITOMYCIN-C (MIT C) AGAINST LEUKEMIA P388 (P388) IN MICE
    SCHABEL, FM
    LASTER, WR
    TRADER, MW
    MOWSHOWITZ, SL
    SMITH, GD
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1982, 23 (MAR): : 190 - 190
  • [8] LEUKEMIA P388-TUMORS RESISTANT TO VINCRISTINE (P388/VCR), ADRIAMYCIN (P388/ADR), OR ARABINOSYLCYTOSINE (P388/ARA-C) - CROSS-RESISTANCE (P388/VCR AND P388/ADR) AND COLLATERAL SENSITIVITY (P388/ARA-C) TO HOMOHARRINGTONINE (H) (NSC 141633)
    WILKOFF, LJ
    DULMADGE, EA
    TRADER, MW
    SCHABEL, FM
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1982, 23 (MAR): : 199 - 199
  • [9] THERAPEUTIC SYNERGISM (TS) OF HOMOHARRINGTONINE (H) PLUS 5-FLUOROURACIL (FU) AGAINST LEUKEMIA P388 (P388/0) AND ARA-C-RESISTANT P388 (P388/ARA-C)
    LASTER, WR
    TRADER, MW
    SCHABEL, FM
    CORBETT, TH
    GRISWOLD, DP
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1982, 23 (MAR): : 199 - 199
  • [10] DEVELOPMENT AND CHARACTERIZATION OF A SUBLINE OF P388 LEUKEMIA RESISTANT TO BIS(DIPHENYLPHOSPHINO)ETHANE
    MCCABE, FL
    FAUCETTE, LF
    BARTUS, JO
    SUNG, CM
    JENSEN, BD
    RUSH, GF
    MIRABELLI, CK
    JOHNSON, RK
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 315 - 315
12345